Combined prognostic importance of CA 125, histopathologic grade and DNA-index in advanced ovarian cancer

European Journal of Gynaecological Oncology

Volumn 21, Issue 6, 2000, Pages 569-572

  Nyvang, G B ^a   Mogensen, O ^a   Bichel, P ^a   Jakobsen, A ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

Author keywords

CA 125; DNA index; Epithelial ovarian cancer; Histopathologic grade; Prognosis

Indexed keywords

CA 125 ANTIGEN;

ADULT; ADVANCED CANCER; ANTIGEN DETECTION; CANCER CHEMOTHERAPY; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; OVARY CANCER; PROGNOSIS; WORLD HEALTH ORGANIZATION;

CA-125 ANTIGEN; CYSTADENOCARCINOMA, SEROUS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034469572     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
2. The role of CA 125 in the early diagnosis of progressive disease in ovarian cancer
3. An assessment of the value of serum CA 125 measurements in the management of epithelial ovarian caminoma
4. Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group Study
5. Ovarian cancer: The prognostic value of the serum half-life of CA 125 during induction chemotherapy
6. A CA 125 score as a prognostic index in patients with ovarian cancer
7. Prognostic value of CA 125 in advanced ovarian cancer
8. Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma
9. Prognostic significance of DNA index in advanced ovarian cancer
10. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma
11. I. Dose-effect study of carboplatin in ovarian cancer: A Danish Ovarian Cancer Group Study
12. CA 125 in the diagnosis of pelvic masses
13. Prognostic impact of ploidy level in carcinoma of the cervix
14. The use of trout erythrocytes and human-lymphocytes for standardization in flow cytometry
15. Use of CA 125 to Predict Survival of patients with ovarian carcinoma
16. DNA index by flow cytometric analysis: An additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation
17. Influence of cellular DNA content on survival in ovarian carcinoma
18. Influence of variate analyses of DNA index, p62c-myc, and clinocopathological status of patients with ovarian cancer
19. Flow cytometric analysis of DNA content in human ovarian cancers